STINGel: Controlled Release of a Cyclic Dinucleotide for Enhanced Cancer Immunotherapy

Recent advancements in the field of immunotherapy have yielded encouraging results for the treatment of advanced cancers. Cyclic dinucleotides (CDNs) are a powerful new class of immunotherapy drugs known as STING (Stimulator of Interferon Genes) agonists, currently in clinical trials. However, previ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials
Hauptverfasser: Leach, David G., Dharmaraj, Neeraja, Piotrowski, Stacey L., Lopez-Silva, Tania L., Lei, Yu, Sikora, Andrew G., Young, Simon, Hartgerink, Jeffrey D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5840037/
https://ncbi.nlm.nih.gov/pubmed/29454236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2018.01.035
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge